When you think of “kindling,” think of confusing. Controversy. Cure.
No, it’s not the little twigs for a bonfire!
But the name “kindling” was inspired by a log fire.
After talking to a famous epileptologist, I learned that calcium is really a two-edged sword. Which surprised (and scared) me.
I’ve always read that calcium was imperative if you were taking antiepilepsy drugs — especially Dilantin. Even if your doc “forgot” to tell you!
Speaking of which, a survey found that fewer than one-third of neurologists routinely evaluated AED patients for bone disease. And fewer than 10% prescribed Calcium and Vitamin D.
To say the word “Keppra,” is to invite instant controversy. For some people it works, for some it doesn’t and for others, it’s a living nightmare.
Yet two different studies found that clinically significant behavioral consequences of Keppra were eight percent, no higher, and maybe even lower, than those reported for other new antiepileptic drugs.
John Gates, M.D., lead investigator of the adult study, neurologist at Minnesota Epilepsy Group and clinical professor of neurology at the University of Minnesota said: “The efficacy of Keppra in treating seizures, coupled with our findings of its low side-effect profile, makes it an option that should be considered, especially for those who have struggled with other treatments.”
Interestingly, both studies evaluated patients with epilepsy who were proven to be drug resistant to other medications.